• On 3 March 2026, Benchmark reaffirmed its positive analyst rating on Aeluma, Inc., citing Nvidia’s recent optical investments as an important sector reference point for the company’s technology focus.
• This endorsement underscores how investor attention around Aeluma is increasingly tied to perceived alignment with larger industry players pursuing advanced optical solutions for AI infrastructure.
• We’ll now examine how Benchmark’s renewed confidence, anchored in Nvidia’s optical investment push, may influence Aeluma’s broader investment narrative.

AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Aeluma Investment Narrative Recap

To own Aeluma, you need to believe its compound semiconductor platform can move from government backed R&D into meaningful commercial volumes across AI infrastructure and defense. Benchmark’s reaffirmed positive rating, framed by Nvidia’s optical investments, adds validation to that thesis but does not materially change the near term catalyst, which is converting Aeluma’s 20 active commercial engagements into design wins. The biggest current risk remains elevated spending ahead of only modestly higher fiscal 2026 revenue guidance.

The most relevant recent update here is Aeluma’s reaffirmed fiscal 2026 revenue outlook of US$4.0 million to US$6.0 million on 11 February 2026. In the context of Benchmark’s renewed confidence, this relatively modest guidance keeps the focus on execution risk: scaling outsourced U.S. foundry and packaging partners, while proving the technology can support multi million unit shipments without stretching the cost base beyond what early commercial wins can support.

Yet behind the optimism around AI optics, investors should also be aware of how quickly rising operating expenses could outpace...

Aeluma's narrative projects $63.3 million revenue and $9.0 million earnings by 2028. This requires 124.9% yearly revenue growth and a $12.8 million earnings increase from -$3.8 million today.

Uncover how Aeluma's forecasts yield a $25.50 fair value, a 39% upside to its current price.

Exploring Other Perspectives

Five fair value estimates from the Simply Wall St Community span a wide US$1.58 to US$25.50 range, showing how far apart individual views can be. Against this backdrop, Aeluma’s need to convert an expanding customer funnel into tangible commercial orders may be a key factor shaping which of these expectations looks more realistic over time, so you should compare several of these viewpoints for yourself.

Explore 5 other fair value estimates on Aeluma - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Aeluma research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free Aeluma research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Aeluma's overall financial health at a glance.

Contemplating Other Strategies?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.
• Capitalize on the AI infrastructure supercycle with our selection of the 35 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.